XML 85 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2013
2000 Employee Option Plan
Dec. 31, 2013
2009 Employee Option Plan
Dec. 31, 2013
2000 Employee Option Plan and 2009 Employee Option Plan
Dec. 31, 2013
2004 Directors Option Plan
Dec. 31, 2013
2012 Directors Restricted Stock Plan
Dec. 31, 2013
Stock Options
Dec. 31, 2012
Stock Options
Dec. 31, 2011
Stock Options
Dec. 31, 2010
Stock Options
Jun. 30, 2013
Restricted Shares
Jun. 30, 2013
Restricted Shares
Dec. 31, 2013
Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award                        
Number of additional stock options that can be granted (in shares) 0                      
Shares available for the granting of additional stock options   2,356,150   70,000 95,131              
Options ratable vesting period     5 years 3 years                
Options exercisable period     10 years 10 years                
Number of additional stock options expected to be granted (in shares)       0                
Stock option activity                        
Options outstanding at the beginning of the period (in shares)           13,446,719 14,016,900 12,706,324        
Options granted (in shares)           2,788,000 2,990,000 2,551,350        
Options exercised (in shares)           (2,636,213) (3,252,961) (1,037,674)        
Options forfeited (in shares)           (176,280) (307,220) (203,100)        
Options outstanding at the end of the period (in shares)           13,422,226 13,446,719 14,016,900 12,706,324      
Vested and non-vested expected to vest at the end of the period (in shares)           12,159,914            
Exercisable at the end of the period (in shares)           5,405,305            
Weighted Average Exercise Price                        
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share)           $ 43.39 $ 38.00 $ 33.93        
Weighted average exercise price, options granted (in dollars per share)           $ 78.00 $ 53.31 $ 53.45        
Weighted average exercise price, options exercised (in dollars per share)           $ 36.46 $ 29.33 $ 25.14        
Weighted average exercise price, options forfeited (in dollars per share)           $ 53.65 $ 42.84 $ 39.75        
Weighted average exercise price, options outstanding at the end of the period (in dollars per share)           $ 51.80 $ 43.39 $ 38.00 $ 33.93      
Weighted average exercise price, vested and non-vested expected to vest (in dollars per share)           $ 51.20            
Weighted average exercise price, exercisable (in dollars per share)           $ 41.09            
Weighted Average Remaining Contractual Term                        
Weighted average remaining contractual term of options outstanding           7 years 29 days 7 years 29 days 6 years 10 months 20 days 7 years 2 months 5 days      
Weighted average remaining contractual term of options vested and non-vested expected to vest           6 years 11 months 23 days            
Weighted average remaining contractual term of options exercisable           5 years 6 months 18 days            
Aggregate Intrinsic Value                        
Aggregate intrinsic value of options outstanding (in dollars)           $ 501,706            
Aggregate intrinsic value of options, vested and non-vested expected to vest (in dollars)           461,873            
Aggregate intrinsic value of options exercisable (in dollars)           259,938            
Status of the Company's non-vested options and changes during the year                        
Non-vested options at the beginning of the period (in shares)           7,951,177            
Non-vested options, options granted (in shares)           2,788,000            
Non-vested options, options vested (in shares)           (2,545,976)            
Non-vested options, options forfeited (in shares)           (176,280)            
Non-vested options at the end of the period (in shares)           8,016,921 7,951,177          
Weighted Average Fair Value at Grant Date                        
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share)           $ 13.36            
Weighted average fair value at grant date, options granted (in dollars per share)           $ 17.42 $ 12.96 $ 14.19        
Weighted average fair value at grant date, options vested (in dollars per share)           $ 13.33            
Weighted average fair value at grant date, options forfeited (in dollars per share)           $ 13.95            
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share)           $ 14.77 $ 13.36          
Total intrinsic value of stock options exercised (in dollars)           105,756 95,891 29,697        
Total fair value of stock options vested (in dollars)           33,932 30,964 28,563        
Total compensation cost related to non-vested options not yet recognized (in dollars)           84,230            
Weighted average expected amortization period           3 years 4 months 6 days           4 months 20 days
Number of restricted shares issued                   12,824 17,045  
Weighted-average grant date fair value of restricted shares (in dollars per share)                   $ 78.00 $ 53.78  
Total compensation cost related to non-vested restricted shares not yet recognized (in dollars)                       $ 394